
LifeArc Joins Transatlantic Collaboration to Develop a Treatment for Crimean-Congo Hemorrhagic Fever
Newswise — A new transatlantic collaboration between the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) and LifeArc will look to develop an affordable and accessible monoclonal antibody therapeutic for Crimean-Congo Hemorrhagic …